Across TCGA pan-cancer cohorts, RAET1E-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RAET1E-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RAET1E-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types RAET1E-AS1 is over-expressed in tumor, although a few such as HNSC and KIRP show the opposite, repressed pattern.

HNSC, THCA, and KIRP are the cancer types where RAET1E-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RAET1E-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	−0.343	<.001	8	view →
THCA	Female	III,IV	+0.271	.018	4	view →
KIRP	Male	All	−0.145	<.001	3	view →
PRAD	All	All	+0.216	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RAET1E-AS1 RNA expression & survival · all RAET1E-AS1 data types